Medical device mergers & acquisition activity is as scarce in 2012 as during the global financial meltdown in 2009, perhaps because of a concurrent flurry of CEO turnovers.
medtech companies have announced $20 billion worth of deals so far for 2012, less than half of the $53.32 billion worth posted in 2011, according to a Thomson Reuters report.